MHLW Pharmaceuticals and Medical Devices Safety Information (FY2026)

FY 2026 (No.428-)
Issue	No.	Table of contents
July 2026	430	Full text [614 KB] Article 1. Revision of "PRECAUTIONS" for lithium carbonate Article 2. Serious hepatic impairment caused by avacopan Article 3. Revisions of PRECAUTIONS (No. 370) Article 4. List of Products Subject to Early Post-marketing Phase Vigilance
May 2026	429	Full text [1,534 KB] Article 1. The Manuals for Management of Individual Serious Adverse Drug Reactions Article 2. The Survey Results on the Status of Acquisition, Communication, and Use of Drug Safety Information at Hospitals and Pharmacies and Desirable Directions Article 3. Important Safety Information Article 4. Revisions of PRECAUTIONS (No. 369) Article 5. List of Products Subject to Early Post-marketing Phase Vigilance
April 2026	428	Full text [473 KB] Article 1. Precautions for antiepileptic drugs concerning driving a car, etc Article 2. Points to consider in taking safety measures when Notification on concomitant drugs are applied Article 3. Important Safety Information Article 3.-1 Olaparib Article 4. Revisions of PRECAUTIONS (No.368) Article 4.-1 Colchicine , and 48 others Article 5. List of Products Subject to Early Post-marketing Phase Vigilance